U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H24O2
Molecular Weight 272.382
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALFATRADIOL

SMILES

[H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(O)C=C4

InChI

InChIKey=VOXZDWNPVJITMN-SFFUCWETSA-N
InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H24O2
Molecular Weight 272.382
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Alfatradiol (17a-estradiol, Ell-Cranell® alpha) is a stereoisomer of the female hormone 17b-estradiol. It inhibits the conversion of testosterone to the metabolite dihydrotestosterone (DHT) by suppressing 5a-reductase activity. In addition, by inhibiting 17b-dehydrogenase, it impedes the conversion process of androstenedione to testosterone, resulting in a reduction in the syntheses of testosterone and DHT. It also accelerates the conversion of testosterone to estradiol by stimulating aromatase, decreasing the level of testosterone and leading to a reduction in DHT. In addition, alfatradiol (17a-estradiol) has been reported to stimulate the generation of hair follicular matrix cells.

Approval Year

PubMed

PubMed

TitleDatePubMed
Combined effects of estrogen and progesterone on the anterior cruciate ligament.
2001 Feb
Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle.
2001 Jan
Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
2001 Jul-Aug
Binding of estrogen and progesterone-BSA conjugates to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the effects of the free steroids on GAPDH enzyme activity: physiological implications.
2001 Jun
Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments.
2001 Nov
Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors.
2001 Nov 2
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
2001 Nov-Dec
Calcineurin as a potential contributor in estradiol regulation of hippocampal synaptic function.
2002
Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol.
2002 Jul
Topical estrogens: their effects on connective tissue synthesis in hairless mouse skin.
2002 Jul
Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model.
2002 Jun
17beta-Estradiol reduces excitatory postsynaptic potential (EPSP) amplitude in rat basolateral amygdala neurons.
2002 Oct 11
Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice.
2003 Apr
Estradiol regulates the slow Ca2+-activated K+ current in hippocampal pyramidal neurons.
2003 Jul 16
Stationary phase with specific surface properties for the separation of estradiol diastereoisomers.
2003 Jul 25
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate].
2003 May-Jun
Characterization of an organic anion transport system in a placental cell line.
2003 Nov
17Beta-estradiol as a receptor-mediated cardioprotective agent.
2003 Oct
Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress.
2004
The unusual binding properties of the third distinct teleost estrogen receptor subtype ERbetaa are accompanied by highly conserved amino acid changes in the ligand binding domain.
2004 Jun
Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?
2004 May 4
Patents

Sample Use Guides

Ell-Cranell® alpha was applied once a day at 3 ml/application using a pre-dosed applicator, and the head was massaged for approximately one minute to facilitate the absorption of the drug.
Route of Administration: Topical
17a- and 17b-estradiol caused a concentration-dependent inhibition of spontaneous rat uterine contractility, with an IC50 value of 89.39 and 8.42 uM, respectively.
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:51:16 GMT 2023
Edited
by admin
on Sat Dec 16 15:51:16 GMT 2023
Record UNII
3VQ38D63M7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALFATRADIOL
INN   MART.  
INN  
Official Name English
ESTRA-1,3,5(10)-TRIENE-3,17.ALPHA.-DIOL
Systematic Name English
ESTRADIOL, .ALPHA.-
Common Name English
ALFATRADIOL [MART.]
Common Name English
17ALPHA-ESTRADIOL
Common Name English
ESTRADIOL, ALPHA-
Common Name English
.ALPHA.-ESTRADIOL [MI]
Common Name English
ETHINYLESTRADIOL IMPURITY L [EP IMPURITY]
Common Name English
17.ALPHA.-ESTRADIOL
Common Name English
17a-estradiol [WHO-DD]
Common Name English
alfatradiol [INN]
Common Name English
ESTRADIOL HEMIHYDRATE IMPURITY B [EP IMPURITY]
Common Name English
ESTRADIOL 17-.ALPHA.
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1740
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL286452
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
SMS_ID
100000092026
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
NCI_THESAURUS
C81622
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
RXCUI
1926478
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
FDA UNII
3VQ38D63M7
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
INN
8057
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
MESH
C519808
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
PUBCHEM
68570
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID8022377
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
CHEBI
17160
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
DAILYMED
3VQ38D63M7
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
EVMPD
SUB12672MIG
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
WIKIPEDIA
ALFATRADIOL
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
CAS
57-91-0
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
MERCK INDEX
m5029
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
200-354-8
Created by admin on Sat Dec 16 15:51:16 GMT 2023 , Edited by admin on Sat Dec 16 15:51:16 GMT 2023
PRIMARY
Related Record Type Details
TARGET->STIMULATOR
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY